Related Experiment Videos
Co-morbidity and health outcomes in three Auckland hospitals
Peter Davis1, Roy Lay-Yee, Julie Fitzjohn
1Department of Public Health and General Practice, Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch. peter.davis@chmeds.ac.nz
Insights
A third of inpatients have co-morbid disease, impacting health outcomes. The Charlson Index effectively predicts outcomes, similar to simply noting the presence of co-morbidity.
Area of Science:
- Health Services Research
- Clinical Epidemiology
Background:
- Co-morbid disease significantly impacts hospital patient outcomes.
- The Charlson Index is a widely used tool for quantifying co-morbidity burden.
Purpose of the Study:
- To determine the prevalence of co-morbid disease using the Charlson Index in Auckland public hospital inpatients.
- To investigate the association between co-morbidity and key health outcomes.
Main Methods:
- Systematic sampling of 1575 medical records from three Auckland public hospitals (1995 admissions).
- Application of the Charlson Index to record co-morbid conditions.
Main Results:
- One-third of patients presented with co-morbid disease, most commonly chronic pulmonary disease and congestive heart failure.
- The Charlson Index correlated with patient age, length of stay, mortality, and adverse events.
- Simple presence/absence of co-morbidity predicted outcomes as effectively as the full index.
- Co-morbidity recording varied by ethnicity (Maori), socioeconomic status, and diagnosis type.
Conclusions:
- Co-morbidity prevalence in Auckland is comparable to international levels.
- Co-morbidity is a significant predictor of clinically and managerially relevant health outcomes.
- Accounting for co-morbidity is crucial for accurate quality of care comparisons.
Aims:
To establish the burden of co-morbid disease using the Charlson Index among hospital inpatients and its relationship to key health outcomes.
Methods:
An initial screen was carried out on 1575 medical records selected by systematic list sample from admissions for 1995 in three public hospitals in the Auckland region. In the course of the administration of the instrument, screeners were required to record the occurrence of co-morbid disease using the Charlson Index.
Results:
A third of patients had co-morbid disease, of which chronic pulmonary disease and congestive heart failure were the most frequently recorded. While the Charlson Index was associated with age of patient, length of stay, inpatient mortality, and adverse event status, the simple presence or absence of co-morbidity was as an effective predictor as the extended index. Co-morbidity was more likely to be recorded for Maori, for patients from deprived areas, and for circulatory or respiratory diagnoses. Specific co-morbid conditions were predictive of health outcomes.
Conclusions:
Levels of co-morbid disease established for patients using the Charlson Index in three Auckland public hospitals are similar to those recorded internationally. Co-morbidity is predictive of key health outcomes that are of clinical and managerial significance. Controlling for co-morbidity will be important in making comparisons of the quality of care.
Related Concept Videos
Tertiary Healthcare System
Hospitals-I
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Hospitals-II
Nurses that work in hospitals have...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...